In addition, ANXA2 was found to promote mitochondrial membrane fusion by regulating optic atrophy 1 (OPA1) expression in non-small cell lung cancer, thereby enhancing mitochondrial metabolic adaptation and preventing apoptosis [86]. The gene discussed is ANXA2; the disease is non-small cell lung carcinoma.